Clinical Trials Browser

Withdrawn × Carcinoma, Hepatocellular × Bevacizumab × Clear all

NCT05886257 2023-06-02

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT01441388 2011-12-20

A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Phase 1 Withdrawn

CNSGastrointestinalGenitourinary

Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular